Found: 12
Select item for more details and to access through your institution.
C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 636, doi. 10.1111/1759-7714.14798
- By:
- Publication type:
- Article
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 624, doi. 10.1111/1759-7714.14796
- By:
- Publication type:
- Article
MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 612, doi. 10.1111/1759-7714.14791
- By:
- Publication type:
- Article
Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 602, doi. 10.1111/1759-7714.14788
- By:
- Publication type:
- Article
Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 592, doi. 10.1111/1759-7714.14785
- By:
- Publication type:
- Article
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 535, doi. 10.1111/1759-7714.14783
- By:
- Publication type:
- Article
TAPO in first‐line osimertinib therapy and continuation of osimertinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 584, doi. 10.1111/1759-7714.14782
- By:
- Publication type:
- Article
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 573, doi. 10.1111/1759-7714.14781
- By:
- Publication type:
- Article
Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 563, doi. 10.1111/1759-7714.14780
- By:
- Publication type:
- Article
Higher aorta dose increased neutrophil‐to‐lymphocyte ratio resulting in poorer outcomes in stage II‐III non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 555, doi. 10.1111/1759-7714.14778
- By:
- Publication type:
- Article
Circular RNA hsa_circ_0008003 promotes the progression of non–small‐cell lung cancer by sponging miR‐548I and regulating KPNA4 expression.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 544, doi. 10.1111/1759-7714.14777
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 6, p. 533, doi. 10.1111/1759-7714.14492
- Publication type:
- Article